$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What is the real reason why obeticholic acid has been discontinued in the country?
2026-02-01 22:25:32
Check Details
Introduction to the role and main efficacy of neratinib/neratinib
2026-02-01 22:25:32
Check Details
What are the current clinical indications for bedaquiline?
2026-02-01 22:25:32
Check Details
How much is the latest price of dasatinib in 2025?
2026-02-01 22:25:32
Check Details
How do you feel after taking Anamorelin?
2026-02-01 22:25:32
Check Details
How much is the latest price of a box of tucatinib/tucatinib?
2026-02-01 22:25:32
Check Details
Apelix-Piqray’s instructions provide detailed instructions on usage and dosage.
2026-02-01 22:25:32
Check Details
What is the real and latest price of a box of fotantinib/fotantinib?
2026-02-01 22:25:32
Check Details
What is the approximate market price of a box of lenvatinib/lenvatinib?
2026-02-01 22:25:32
Check Details
What is the current approximate market price of Fezonatant tablets?
2026-02-01 22:25:32
Check Details
What diseases are Besudil mesylate tablets mainly used to treat?
2026-02-01 22:25:32
Check Details
What is the latest market price of Brivaracetam in 2025?
2026-02-01 22:25:32
Check Details
1
2
...
1567
1568
1569
1570
1571
1572
1573
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
2
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
3
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
4
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
5
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
6
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
7
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
8
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
9
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
10
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
11
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
12
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis